Provided By PR Newswire
Last update: Oct 15, 2025
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx
Constellation outperformed orthogonal methods in identifying select difficult-to-map variants
Read more at prnewswire.com134.87
-1.57 (-1.15%)
151.51
-3.86 (-2.48%)
Find more stocks in the Stock Screener


